REFERENCES
- Nissenson AR, Swan SK, Lindberg JS, Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis. 2002;40:110–118.
- Macdougall IC, Padhi D, Jang G. Pharmacology of darbepoetin alfa. Nephrol Dial Transplant. 2007;22(4):iv2–iv9.
- Jabr F, Taher A. Recurrent skin reaction secondary to darbepoetin alfa for two months in a patient with chronic lymphocytic leukemia. Am J Hematol. 2007;82:245
- Steele RH, Limaye S, Cleland B, Chow J, Suranyi MG. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoetin. Nephrology. 2005;10:317–320.
- Cvetkovic RS, Goa KL. Darbepoetin alfa in patients with chemotherapy-related anaemia. Drugs. 2003;63:1067–1074.